Skip to main content
Top
Published in: Obesity Surgery 7/2020

01-07-2020 | Obesity | Brief Communication

Implications of Perioperative Polypharmacy in Adolescents Undergoing Bariatric Surgery: a Single-Center Experience

Authors: Elaine F. Williams, Janelle D. Vaughns, Eleanor R. Mackey, Jane C. Muret, Evan P. Nadler, Johannes N. van den Anker

Published in: Obesity Surgery | Issue 7/2020

Login to get access

Abstract

Adolescents seeking bariatric surgery may present with pre-existing psychiatric diagnoses for which they use chronic medications. To heighten awareness concerning perioperative polypharmacy in adolescents with extreme obesity, we conducted a retrospective review of patients undergoing laparoscopic sleeve gastrectomy between February 2010 and May 2017 at Children’s National Health System (CNHS). A total of 167 adolescent patients had pre-existing psychiatric diagnoses which included depression (50%), anxiety (23%), ADHD (23%), and binge eating disorder (11%). Medications prescribed to treat these diagnoses included selective serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine reuptake inhibitors (SNRIs). Additionally, all patients were given fentanyl, ondansetron, morphine, and acetaminophen perioperatively. Although no life threatening symptoms of drug-drug interactions (DDIs) were appreciated, the combined use of many different potent drugs in these patients warrants attention.
Literature
1.
go back to reference Herget S, Rudolph A, Hilbert A, et al. Psychosocial status and mental health in adolescents before and after bariatric surgery: a systematic literature review. Obes Facts. 2014;7:233–45.CrossRef Herget S, Rudolph A, Hilbert A, et al. Psychosocial status and mental health in adolescents before and after bariatric surgery: a systematic literature review. Obes Facts. 2014;7:233–45.CrossRef
2.
go back to reference Zeller MH, Roehrig HR, Modi C, et al. Health-related quality of life and depressive symptoms in adolescents with extreme obesity presenting for bariatric surgery. Pediatrics. 2006;117:1155–61.CrossRef Zeller MH, Roehrig HR, Modi C, et al. Health-related quality of life and depressive symptoms in adolescents with extreme obesity presenting for bariatric surgery. Pediatrics. 2006;117:1155–61.CrossRef
3.
go back to reference Pratt JS, Lenders CM, Dionne EA, et al. Best practice updates for pediatric/adolescent weight loss surgery. Obes Silver Spring. 2009;17:901–10.CrossRef Pratt JS, Lenders CM, Dionne EA, et al. Best practice updates for pediatric/adolescent weight loss surgery. Obes Silver Spring. 2009;17:901–10.CrossRef
4.
go back to reference Bernard S, Neville KA, Nguyen AT, et al. Inter-ethnic differences in genetic polymorphisms of CYP2D6 in the U.S. population: clinical implications. Oncologist. 2006;11:126–35.CrossRef Bernard S, Neville KA, Nguyen AT, et al. Inter-ethnic differences in genetic polymorphisms of CYP2D6 in the U.S. population: clinical implications. Oncologist. 2006;11:126–35.CrossRef
5.
go back to reference Wang RZ, Vashistha V, Kaur S, et al. Serotonin syndrome: preventing, recognizing, and treating it. Cleve Clin J Med. 2016;11:810–7.CrossRef Wang RZ, Vashistha V, Kaur S, et al. Serotonin syndrome: preventing, recognizing, and treating it. Cleve Clin J Med. 2016;11:810–7.CrossRef
Metadata
Title
Implications of Perioperative Polypharmacy in Adolescents Undergoing Bariatric Surgery: a Single-Center Experience
Authors
Elaine F. Williams
Janelle D. Vaughns
Eleanor R. Mackey
Jane C. Muret
Evan P. Nadler
Johannes N. van den Anker
Publication date
01-07-2020

Other articles of this Issue 7/2020

Obesity Surgery 7/2020 Go to the issue